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Abstract Molecularly imprinted polymers (MIPs) are syn-
thetic receptors that are able to specifically bind their target
molecules in complex samples, making them a versatile tool
in biosensor technology. The combination of MIPs as a
recognition element with quartz crystal microbalances
(QCM-D with dissipation monitoring) gives a straightfor-
ward and sensitive device, which can simultaneously mea-
sure frequency and dissipation changes. In this work, bulk-
polymerized L-nicotine MIPs were used to test the feasibility
of L-nicotine detection in saliva and urine samples. First, L-
nicotine-spiked saliva and urine were measured after dilu-
tion in demineralized water and 0.1× phosphate-buffered
saline solution for proof-of-concept purposes. L-nicotine
could indeed be detected specifically in the biologically
relevant micromolar concentration range. After successfully
testing on spiked samples, saliva was analyzed, which was
collected during chewing of either nicotine tablets with
different concentrations or of smokeless tobacco. The MIPs
in combination with QCM-D were able to distinguish clear-
ly between these samples: This proves the functioning of the
concept with saliva, which mediates the oral uptake of
nicotine as an alternative to the consumption of cigarettes.
Keywords Molecularly imprinted polymers . L-nicotine .
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Introduction
Molecularly imprinted polymers (MIPs) are synthetic recep-
tors that can capture low molecular weight molecules in a
selective manner [1–4]. This makes them a candidate for use
in biomimetic sensing technology [5–7]. Compared to con-
ventional recognition elements, such as antibodies and en-
zymes, they are easily and cheaply produced in large quan-
tities and have a long shelf life as they do not degrade under
ambient circumstances [8, 9]. These characteristics make
them ideal for applications in a variety of scientific fields
like environmental analysis [10], food analysis [11, 12],
separation technology [13, 14], and biosensing [15]. In
biosensing applications, detection of the binding event using
MIPs can be achieved with electrochemical transducers
based on membranes [16], piezoelectric [17], and optical
transducers [18]. Targets for MIP detection can be low
molecular weight molecules [8, 19, 20], proteins [21, 22],
DNA [23], and whole cells [24]. During synthesis, first a
pre-polymerization complex is formed between template
and functional monomers. Then, the preformed complex is
polymerized and fixed by the aid of cross-linker monomers.
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After polymerization, the template molecule is extracted,
thereby leaving tailor-made cavities behind which can se-
lectively rebind the template molecule. The effectiveness of
MIPs in biosensor technology has already been demonstrat-
ed in aqueous media like demineralized water (dH2O) and
phosphate-buffered saline solution (PBS) [25, 26]. The next
step is to verify the usefulness of MIPs in biosensor tech-
nology by detecting the desired molecule in “real-life” ma-
trices such as human blood serum [27, 28], urine [27], saliva
[29], blood plasma [20], natural waters, and soil samples
[10]. In this work, a MIP was created for the detection of L-
nicotine in aqueous media including urine and saliva.
L-nicotine is the major addictive substance found in to-
bacco and is usually taken up in the human body through
smoking, chewing, or sniffing tobacco. In the framework of
nicotine replacement therapies for smoking cessation, nico-
tine can be administered using gums and tablets, nicotine
patches, inhalers, and nasal sprays [30–32]. This raises the
question on the most efficient way of nicotine delivery
keeping in mind that in case of oral intake (gums and
tablets), a large fraction of the nicotine is swallowed and
will not enter the bloodstream. A first quantification of this
lost fraction can be achieved by determining the amount of
nicotine present in saliva. Tobacco smoke, until now the most
common pathway of nicotine intake, contains besides L-nico-
tine more than 4,000 compounds of which more than 50 are
carcinogenic [33]. It has been proven that tobacco consump-
tion causes a higher risk for the development of cancer in the
lungs and respiratory tract [34, 35] and diseases such as
pulmonary disease [36], atherosclerosis [37], and periodontal
disease [38]. The presence of L-nicotine can be determined in
various samples such as urine, hair, breast milk, plasma, and
saliva [39]. The detection of L-nicotine is preferably done in a
noninvasive way with easily obtained samples. Saliva is simply
collected from test persons and, shortly after consumption of
products containing L-nicotine, the concentration of L-nicotine
is higher than the cotinine concentration [40]. It is
important to measure the L-nicotine concentrations in
their natural matrix as this will give the most accurate
result. Detection in saliva has been established with
several methods such as liquid-phase microextraction
and high-performance liquid chromatography coupled
with UV–vis detection [39]. The analysis of L-nicotine
and its oxidation products in nicotine chewing gum has
been reported with molecularly imprinted solid-phase
extraction, but these tests were not yet performed in
saliva [29]. The detection techniques used so far are
complex, time consuming, and require trained personal,
which makes them disadvantageous. Quartz crystal
microbalance-dissipation (QCM-D) provides a fast, easy,
and reliable testing platform for the use of MIPs in
combination with body fluids. MIPs are immobilized
on the quartz crystal via a polyvinyl chloride (PVC)
adhesion layer. When L-nicotine binds to the MIP, the
resonance frequency of the quartz crystals will shift
according to the added mass as described by the
Sauerbrey equation [41]. Binding of the template can
also cause shifts in the dissipation of the functionalized
quartz crystal: This is measured after every excitation
and is an indication for the loss of vibrational energy.
These changes are due to conformational and viscoelas-
tic changes at the surface and can serve also as an
additional read-out technique [42, 43]. In a previous
work, the binding capacities of the MIP were already
studied in L-nicotine-spiked dH2O and PBS using the
QCM-D setup, showing specific binding of the target in
both fluids [43]. In this contribution, the MIPs’ efficien-
cy to bind L-nicotine in more complex fluids was tested
with saliva and urine samples. As a start, the saliva and
urine samples were spiked with L-nicotine and subse-
quently diluted with dH2O or PBS. For further valida-
tion of the sensor, a test person was instructed to chew
nicotine chewing gums with a concentration of 2 or
4 mg L-nicotine to obtain saliva samples with different
concentrations. As a second trial, a test person was
instructed to consume smokeless tobacco. These saliva
samples were tested with the MIP sensor to investigate
whether the L-nicotine can be detected in these matrices.
The various tests demonstrate the practicality, specifici-
ty, and sensitivity of the MIP-based QCM-D sensor
platform for these analytical tasks.
Materials and methods
Reagents
The molecularly imprinted polymer was synthesized using
ethylene glycol dimethacrylate (EGDM) as the cross-linker,
methacrylic acid (MAA) as functional monomer, and hex-
ane as the porogen. Prior to polymerization, the stabilizers in
the MAA and EGDM were removed by passing through an
alumina column. For the initiator, azobisisobutyronitrile
(AIBN) was used. All chemicals employed in the polymeri-
zation were of analytical grade and obtained from various
commercial sources. The PVC adhesive was purchased from
Fig. 1 Structure of L-nicotine
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Sigma-Aldrich NV/SA, Bornem, Belgium. The target mole-
cule L-nicotine, C10H14N2 (MW, 162.23 Da; see Fig. 1 for the
chemical structure), was obtained from Acros Organics, Geel,
Belgium. The nicotine chewing gums (Nicorette®, Johnson &
Johnson NV, Beerse, Belgium) were used in concentrations of
2 and 4 mg L-nicotine per tablet while nicotine-free “taste
samples” of the Nicorette® gumswere employed for reference
purposes. The smokeless tobacco was Skoal® Wintergreen
Longcut, Stamford, CT, USA.
Equipment
The morphology of the sensor surface was studied by optical
microscopy with a Zeiss Axiovert 40 MAT (Carl Zeiss, Jena,
Germany). Microscope images were processed using the image
analysis program ImageJ 1.37v from the National Institute of
Health, Bethesda, USA. Quartz crystals (5 MHz) with Cr/Au
electrodes were purchased from LOT-Oriel (Darmstadt, Ger-
many). The QCM system (Q-sense E4) was also purchased
from LOT-Oriel (manufacturer Q-Sense, Gothenburg, Swe-
den). A flow setup was established with a peristaltic pump
(IPC-N) from Ismatec.
MIP synthesis
For the preparation of the L-nicotine MIP, a mixture of MAA
(12.5 mmol), EGDM (25.5 mmol), and AIBN (0.66 mmol)
was dissolved in 7 ml hexane together with the template
molecule L-nicotine (6.41 mmol). To exclude oxygen in the
mixture, it was degassed for 10 min with N2. Subsequently for
polymerization, the solution was sealed and kept in a thermo-
static water bath at 60 °C (72 h). After polymerization, the solid
MIP was ground with a mechanical mortar (24 h) and passed
through a 25-μm sieve. Only particles with a size smaller than
25 μm were used. Next, the L-nicotine was extracted from the
MIP powder by extensive washing with methanol (48 h),
followed by a mixture of acetic acid/acetonitrile (1/1) (48 h)
and finally again with methanol (12 h) using a continuous
extraction setup. A non-imprinted polymer (NIP) was synthe-
sized as a reference material in the same way but without the
presence of the target molecule.
Sensing system
The QCM crystals have a resonance frequency of 5 MHz
and are modified with Cr/Au electrodes. The Q-Sense E4
system allows for simultaneous measurements of up to four
crystals. The system is temperature controlled and was kept
at 22.00±0.01 °C throughout the measurements. On the top
electrode, a layer of PVC (PVC 0.35 wt% in tetrahydrofu-
ran) was spin coated (5,000 rpm with 990 rpm/s) to obtain a
layer of 100-nm thickness. TheMIP was then applied onto the
surface using a poly(dimethylsiloxane) stamp, which was
pressed against the active sensing surface. This resulted in a thin
layer ofMIPs on the surface. Subsequently, the PVCwas heated
to 120 °C for 15 min. As this temperature is well above the
glass transition temperature of 80 °C, the MIP particles
partially sink into the polymer layer. The samples were
then cooled and the excessiveMIP powder was rinsed off with
deionized water. QCM measurements were performed as fol-
lows: First, the system was left to stabilize in the fluid (dH2O
or 0.1× PBS at pH 9) in which the performance of the MIP
was to be tested. This was at a flow rate of 200 μl/min. After
the signal was stable, L-nicotine-spiked saliva or urine samples
were diluted with the measuring fluid (dH2O or PBS) to
achieve various concentrations that were then consecutively
connected to the flow system starting with the lowest concen-
tration while keeping the flow rate constant. In between the
exposures to the different concentrations, the sensor was
flushed with dH2O in order to ensure the recovery to the
sensor baseline before testing the next higher concentration.
This results in a dose–response curve for the frequency and
dissipation of the QCM-D system. The frequency noise
was 0±0.84 Hz on average while the noise on the dissi-
pation signal was 0±0.43×10−6 on average. All measure-
ments were performed six times per concentration in dH2O
or 0.1× PBS at pH 9. In the “Results and discussion” section,
the average response per concentration is presented while the
error bars correspond to the standard deviation.
Sample preparation
In Fig. 2, the sample preparation protocol is schematically
presented. In order to collect saliva, a nonsmoker test
person was asked to deposit saliva in a sterilized Falcon
tube every minute until the desired amount of 40 ml
was met. This saliva was immediately centrifuged for
10 min with 10,000 rpm at 8 °C (a). The supernatant
was collected (b) and filtered using 1 μm syringe filters
(c). This resulting saliva sample was split in two parts.
One part of the collected saliva was spiked with L-
nicotine (100 mM) (d) while the other half was unaltered
(e) serving as a control fluid. The same procedure was used on
urine samples. Fluids were stored at −18 °C to prevent degra-
dation. For measurement purposes, the L-nicotine-spiked sali-
va and urine samples were diluted from the stock solution to
the desired concentrations using dH2O or PBS. These are
indicated as “spiked with L-nicotine” in the resulting graphs.
For example, a nicotine concentration of 100 μM was
obtained by diluting 20 μl of the 100 mM stock solution
(volume measured with a micropipette, precision <0.5 μl)
with dH2O or PBS to a final volume of 20 ml. The non-
spiked saliva and urine sample volumes used are the same as
the volumes of the L-nicotine-spiked samples used to create
the corresponding concentration. These are indicated as “with-
out L-nicotine” in the resulting graphs.
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Results and discussion
An average surface coverage of the QCM crystals was
19.4 % for the MIP and 20.2 % for the NIP powders,
which is consistent with previously reported surface
coverage values [26]. All shown QCM-D results (except
for the raw data in Fig. 3a) are differential data where
the nonspecific NIP response was subtracted from the
MIP response. The NIP channel serves as a control and
will show the nonspecific binding, while the MIP rep-
resents the specific binding of L-nicotine on top of
nonspecific events. By subtracting the NIP from the
MIP response, the specific binding of the L-nicotine is
obtained, which gives a direct insight in the perfor-
mance of the sensor.
L-nicotine detection in saliva
The saliva was collected according to the “Sample presen-
tation” section. One part was spiked with L-nicotine
(100 mM) and subsequently diluted with dH2O or 0.1×
PBS of pH 9 to obtain the required concentrations. The
other part remained unaltered and served as a control. The
results of these measurements are shown in Fig. 3.
As can be seen in Fig. 3a, the MIP and NIP gave no
significant frequency response with non-spiked saliva of
a nonsmoking test person. This means that there is little
tendency to bind other molecules than L-nicotine in
saliva. With spiked saliva, the frequency drop for the
MIP is significantly stronger than for the NIP, indicating
specific binding of the L-nicotine. Figure 3b shows the
MIP–NIP difference signal between spiked- and non-
spiked saliva. With the spiked saliva, the frequency
drops in a sublinear way with increasing concentration.
A spiked concentration of 20 μM L-nicotine results in a
frequency shift of 10±4 Hz, while a spiked concentra-
tion of 100 μM L-nicotine causes a 37±5-Hz frequency
drop. To give an estimate for the limit of detection
(LOD) and the limit of quantification (LOQ), we con-
sider the initial, linear slope, which is −0.48 Hz/μM.
The uncertainty of the frequency measurement is 1.7 Hz
(two times the frequency noise of ±0.84 Hz) and the
LOD (three times the uncertainty) will therefore corre-
spond to 10.6 μM while the LOQ (five times the
uncertainty) is 17.7 μM. The saliva sample without L-
nicotine does not show a frequency drop and stays
stable, suggesting that nonspecific binding to MIP and
to NIP is comparable and weak. This means that the
MIP is able to recognize and bind the L-nicotine present
in the spiked saliva in a specific manner. While mea-
suring the frequency change, the QCM-D simultaneous-
ly measures changes in the dissipation. The same ex-
periment was also performed with saliva diluted in 0.1×
PBS at pH 9, as PBS mimics the ionic composition of
body liquids. The pH of 9 was used on purpose because
earlier studies suggested that the employed MIP has an
optimal binding capacity for L-nicotine at this pH value
[43]. From Fig. 3c, it is clear that the sensitivity of the
MIP decreases significantly in comparison to measure-
ments in dH2O. A concentration of 100 μM of L-nico-
tine results in a 15±4-Hz frequency drop in 0.1× PBS
at pH 9 while in dH20, the frequency drop is 37±5 Hz.
On average, the MIP is able to bind almost three times
more L-nicotine from the same spiked saliva sample
when measured in dH2O than in 0.1× PBS at pH 9.
The lowered binding capacity of the MIP in 0.1× PBS
at pH 9 may be attributed to interfering ions in the
electrolyte, which hinder the formation of hydrogen
bridges between the MIPs and the L-nicotine molecules.
In Fig. 4, the change in dissipation is shown for saliva-
spiked and non-spiked samples, which were diluted in
dH2O. It is apparent that only the L-nicotine-spiked saliva
samples resulted in changes in dissipation, again confirming
that the MIP is able to bind L-nicotine specifically. The
difference between the L-nicotine-spiked sample and the
non-spiked sample is less pronounced than the frequency
Fig. 2 Sample preparation. The collected nonsmoker saliva or urine sample is first centrifuged at 10,000 rpm for 10 min (a) and then the
supernatant is collected (b) and filtered (c). One half is spiked with L-nicotine (d) while the other half is not altered (e)
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changes documented in Fig. 3b, but nevertheless, a distinc-
tion can be made between the two. This proves that also
dissipation measurements can serve for the detection of low
molecular weight molecules in diluted body fluids. The
dissipation is determined by the viscoelastic properties of
the interface between the quartz crystal and the liquid under
study. We point out that the increasing nicotine concentra-
tion goes along with a larger portion of saliva diluted in
dH2O, leading by itself to a higher dissipation. However, the
differential measurement shown in Fig. 4 corrects for this
viscoelastic response, proving that the recognition of nico-
tine alters the viscoelastic behavior of the MIP layer itself.
To our knowledge, this observation has not been reported in
prior literature.
L-nicotine detection in urine
To further prove the ability of MIPs to bind L-nicotine
specifically in complex matrices, the same tests were
performed in urine. Urine was chosen because in smokers’
urine, there are still traces of L-nicotine present. Also, urine
is a complex matrix with a composition distinctly different
from saliva. We mention that most of the L-nicotine is
metabolized in the body to cotinine, which is excreted
through urine [44]. The MIP and NIP were previously tested
for cross selectivity towards cotinine, which did indeed not
show significant binding [43]. Although the other molecules
present in urine differ strongly from the ones present in
saliva, the results obtained with urine samples are similar
Fig. 3 (a) Dose–response curve for the saliva samples spiked with L-
nicotine: the spiked saliva was diluted with dH2O to obtain the required
concentrations. Data for the MIP are given as solid squares while the
NIP data are presented by open squares. The same measurements,
however with non-spiked saliva, are presented as solid diamonds
(MIP) and open diamonds (NIP). (b) Differential MIP–NIP signal for
spiked (solid squares) and non-spiked saliva samples (open squares),
diluted in dH2O. (c) Differential MIP–NIP signal when the spiked
(solid squares) and non-spiked saliva samples (open squares) were
diluted in 0.1× PBS of pH 9
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to the ones obtained with saliva. In Fig. 5, the differential
signal for the L-nicotine-spiked urine and non-spiked urine
is presented. A concentration of 10 μM L-nicotine results in
a frequency shift of 31±1 Hz, while a concentration of
100 μM L-nicotine causes a 54±2-Hz frequency drop. It
should be noted that the signal seems to saturate at a con-
centration of 60 μM. The L-nicotine-spiked samples cause a
stronger frequency change than the non-spiked urine sample
indicating that L-nicotine is specifically bound to MIPs from
the urine matrix. This proves that the MIP can specifically
detect L-nicotine in at least two different diluted body fluids.
Detection of L-nicotine from saliva collected while chewing
nicotine gums and smokeless tobacco
As a confirmation test for the selective and specific binding
of L-nicotine from a complex matrix, the MIP sensor was
applied to saliva samples collected while chewing nicotine
gums with 2 mg and with 4 mg L-nicotine per tablet. The
nicotine-free taste samples of the Nicorette® gums were
used for reference purposes, allowing correcting for a theo-
retical, nonspecific sensor response due to flavorings, col-
orants, and other additives. The test person chewed the
nicotine gums for 60 min, meanwhile collecting saliva in a
sterilized Falcon tube. Prior to collecting saliva, the test
person had no intake of nicotine in any form for at least
24 h in order to avoid possible offset effects. Additionally,
saliva samples were obtained during the consumption of 2 g
of smokeless tobacco (Skoal® Wintergreen) with a nominal
nicotine content of 10 mg L-nicotine per gram as determined
in prior literature [45]. Saliva collection, centrifugation,
filtration, and storage were handled in the same way as for
all other saliva and urine samples (see Fig. 2, except for the
spiking in step D).
Figure 6 shows the differential frequency response (re-
sponse of the MIP-loaded QCM minus the response of NIP-
loaded QCM crystals) for the saliva samples obtained with
0, 2, and 4 mg Nicorette® tablets. For all experiments,
0.25 ml of saliva was diluted in 19.75 ml dH2O to a total
sample volume of 20 ml. Due to this strong dilution, we do
not expect adverse effects on the resonance frequency,
which would be expected due to the viscosity of non-
diluted saliva. Differential sensing is a necessity allowing
to correct for nonspecific adsorption effects inherent to the
Fig. 5 Differential MIP–NIP dose–response curves for urine samples
spiked with L-nicotine (solid squares) and non-spiked urine samples
(open squares). The spiked- and non-spiked urine samples were diluted
in dH2O to obtain the indicated concentrations
Fig. 4 Differential MIP–NIP dose–response curve of the dissipation
signal for increasing concentrations of spiked L-nicotine saliva (solid
squares) and non-spiked saliva (open squares). All measurements were
performed on spiked and non-spiked saliva samples diluted in dH2O
Fig. 6 Differential frequency response of the QCM-D for saliva sam-
ples collected while chewing 4 mg nicotine gum, 2 mg nicotine gum,
and the nicotine-free (0 mg) taste sample. All data are averaged over
six independent measurements. The sensor response of the taste sample
is negligible as compared to the error bar
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complex mixture of proteins and enzymes in saliva and
additives of the Nicorette® tablets. All measurements were
performed six times and averaged while the error bars
represent the scattering of the data. As expected, the stron-
gest signal change is found with the 4-mg samples (21±3 Hz).
It is weaker for the samples obtained with 2 mg tablets (14.5±
1.5 Hz), and with the nicotine-free testing tablet, we measured
a signal change of 1±1 Hz. Within the experimental resolu-
tion, this corresponds to the complete absence of a recognition
effect. Note that the 4-mg samples do not result in twice the
response observed with the 2-mg tablets because consuming
tablets with higher nicotine concentration stimulates a stron-
ger release of saliva, resulting in dilution. In the sense of the
dose–response curve shown in Fig. 3b, the frequency drop of
21 Hz observed with the 4-mg tablet would correspond to a
concentration in the range of 43.8±6.2 μM. Assuming that all
nicotine from the tablet (4 mg, molecular weight
162.23 g/mol) is transferred to saliva (volume of 8.5 ml after
centrifugation and filtering), we expect a nicotine concentra-
tion of 2.9 mM in the actual saliva sample. Keeping in mind
that these samples were diluted 80 times (0.25 ml of saliva in
19.75 ml dH2O), we end upwith a final concentration of about
36 μM. Within the error bars, this is in reasonable agreement
with the value of 44 μM determined from the dose–response
curve. In order to confirm the result obtained with QCM with
a second, independent technique, we analyzed the same saliva
sample with impedance spectroscopy and obtained 43.5±
4.4 μM (using the same degree of dilution). The underlying
methodology and calibration curves can be found in reference
[46], and this indicates that impedance spectroscopy can be
considered as an alternative to the QCM approach described
within this article.
Fig. 7 QCM-D measurements on saliva samples obtained with 4 mg
nicotine tablets and with smokeless tobacco. Each sample was either
extracted with MIP powder (a) or with NIP powder (b) with negligible
nicotine absorption. (c) Differential sensor response for NIP- or MIP-
extracted samples obtained with a 4-mg nicotine tablet. The results for
NIP- and MIP-extracted saliva obtained while consuming smokeless
tobacco are shown in (d)
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Finally, we evaluated whether it is possible to define a
sensor baseline in case that neither nicotine-free tablets nor
nicotine-free saliva is available as reference materials. For
these experiments, two 5-ml samples of diluted saliva (di-
lution as described above) from the “4-mg nicotine batch”
were extracted using either 20 mg of MIP powder or 20 mg
of NIP powder. This procedure is schematically illustrated in
Fig. 7a, b. The extraction treatment was performed for 120 min
at room temperature on a rocking table followed by filtering
and collecting the supernatant. In addition to the extraction of
proteins and enzymes, which is already achieved by the NIP
powder, theMIP powder will also extract the nicotine present in
the diluted saliva sample. It is shown in Fig. 7c that the NIP
extraction has only a minor influence on the sensor response
when compared to the non-extracted samples in Fig. 6. On the
other hand, Fig. 7c demonstrates that extraction with MIP
powder removes all nicotine and, within error bars, the differ-
ential signal remains indeed at the baseline.
The differential sensor response with the NIP-extracted
smokeless tobacco sample corresponds to 39±5 Hz, being
more than twice as strong as the response obtained with the
4-mg nicotine gum samples. This is in principle not surpris-
ing because the nominal total nicotine content of 2 g of
smokeless tobacco is not less than 20 mg. In the sense of the
dose–response curve in Fig. 3b, the frequency drop by
40 Hz is equivalent to a concentration in the range of about
100 μM. Here, we point out that this concentration is only
indicative because smokeless tobacco contains not only flavor-
ings but also salts and pH agents, which stimulate the actual
nicotine uptake via the mucous tissue in the oral cavity. Never-
theless, the experiments indicate that there must be a massive
release of nicotine, exceeding the response obtainedwith tablets
that are usually employed to reduce the withdrawal symptoms
of former smokers.
Conclusion
A MIP with a high affinity and specificity towards L-nico-
tine has been developed for the use in aqueous fluids. This
MIP was successfully integrated in a QCM-D sensor crystal
by immobilizing them into a spin-coated PVC layer on top
of the upper gold electrode. The MIP performance to spe-
cifically bind L-nicotine in biological solutions was tested
with spiked saliva and urine samples diluted into dH2O or
0.1× PBS. First, the MIP was tested with dH2O where it
showed a sublinear frequency response to increasing L-nic-
otine concentration in the lower micromolar range while the
control samples showed no specific response. Dissipation
response results were also promising and may serve as an
alternative way to differentiate between nicotine-spiked and
non-spiked saliva samples. The same experiment was also
performed in 0.1× PBS at pH 9 with L-nicotine-spiked saliva
samples. The frequency response was lower in comparison
with dH2O, but L-nicotine could still be successfully detect-
ed in the micromolar range. The use of the MIP sensor in
patients’ samples was tested with saliva obtained during
chewing of nicotine gums with different standard concen-
trations and while using smokeless tobacco. The sensor was
indeed able to distinguish between different concentrations
of L-nicotine in saliva while chewing nicotine gums. Con-
sistently, we observed a strong nicotine release when con-
suming smokeless tobacco. This illustrates that MIPs are
versatile receptors for small-molecule detection in complex
fluids when combined with quartz crystal microbalances or
other analytical techniques used in the pharmaceutical, en-
vironmental, and bioanalytical sectors.
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